Oryzogen's Orumin® Phase IV Clinical Trial Completes First Dosing | Portfolio News
Oryzogen's Orumin® Phase IV Clinical Trial Completes First Dosing | Portfolio NewsOn March 5, 2026, the Phase IV clinical study of Oryzogen's recombinant human albumin (rice-derived) Orum...
2026
-
03
-
06